Search results for: 'need capture therapy'

As cell and gene therapy (CGT) moves from ultra-rare indications to more common indications, manufacturing capabilities will have to expand to support the commercial requirements of these diseases. Contract research organizations (CROs) can play a critical role in long-term genetic analysis and monitor safety and efficacy up to 15 years after treat...

31 Mar 2017  |  North America  |  Market Research

Future of Diabetes Care Paradigms, Forecast to 2022

Innovations to Disrupt Diabetes Wellness, Diagnosis, Monitoring, and Therapy

Infographics

×

Diabetes management is on the verge of being disrupted by innovative technologies such as artificial pancreas, non-invasive glucose monitoring sensors, wearables, apps, and inhalable insulin. This research study captures all the innovative developments across the segments of wellness, diagnosis, monitoring, and therapy of the diabetes care continuu...

07 Mar 2023  |  Global  |  Technology Research

Global Gut Microbiome Growth Opportunities

Targeted Gut Microbiome Technologies to Drive Transformational Growth Across the Global Healthcare Landscape

Infographics

×

This study identifies and analyzes research initiatives focused on the development of gut microbiome therapeutics. Disruption of the gut microbiome causes a range of health issues, including gastrointestinal diseases, immuno-oncological diseases, and metabolic diseases. Over the last decade, gut microbiome therapeutics have largely relied on untarg...

02 Sep 2015  |  Global  |  Market Research

The New Age of Regenerative Medicine

Why Stem Cell Therapy?

Infographics

×

Cell therapy is the fastest growing segment of the Regenerative Medicine (RM) industry. It comprises both immune cell therapy and stem cell therapy; however, stem cell therapy makes up the largest part of this segment. The global cell therapy market is driven by the success of stem cell treatments in treating or curing life-threatening diseases suc...

This edition of the Industrial Bioprocessing TOE features information on advanced carbon capture technology, plastic recycling, biogas treatment, reverse osmosis, wastewater treatment, cell culture, clean sustainable aviation fuel production and direct air capture, among others.The Industrial Bioprocessing TOE provides intelligence on technologies,...

Worldwide cancer incidence is expected to exceed 35 million new cases by 2050, a 77% rise from the 20 million cases in 2022. Alcohol intake, tobacco usage, obesity, and air pollution are the main causes of this increase. Cancer studies today emphasize cell and gene therapy, antibody-drug conjugates (ADCs), checkpoint inhibitors, and multi-specific...

The bio‑CDMO industry is entering an era of accelerated growth driven by the global shift toward complex biologics, including monoclonal antibodies, antibody-drug conjugates (ADCs), cell and gene therapies, recombinant proteins, and advanced vaccines. Large molecules are projected to record a 10.3% CAGR between 2025 and 2031, signaling sustained de...

This edition of the Industrial Bioprocessing TOE features information on innovations in advanced fermentation technology, biocatalysis application in pharma industry, enzymatic bioconversion, sustainable protein production, plastic recycling, carbon capture, among others.The Industrial Bioprocessing TOE provides intelligence on technologies, proces...

The research service analyses the European testosterone replacement therapies market. Analysis is done on market drivers, restraints and challenges. The market is segmented according to the product segments. Revenue forecasts are also done based on these product segments. Competitive landscape has been analysed and the profiles of competitors ha...